Yup heart surgery is probably completely and utterly out of reach of the majority of the population. Market size? Maybe a rough guide would be to apply the incidence/prevalence of CHD in the population that has private health insurance (going by the above link, thats about 5% of the population or 66 million have private health insurance).
Using the figures used by other posters:
Number of private health insured = 66 million
Population growth = 2% x 66 million = 1.3 million p.a.
Incidence of CHD = 1% x 1.3 million = 13,200 p.a.
Number of operations = 25% x 13,200 = 3,300 p.a.
The country in itself wont be a company maker but its another market to add to the list and for sure over time a progressively larger segment of the population in India will join the ranks of those that can afford proper healthcare.
- Forums
- ASX - By Stock
- Ann: Regulatory approval to launch CardioCel in India
Yup heart surgery is probably completely and utterly out of...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$12.90 |
Change
0.200(1.57%) |
Mkt cap ! $272.6M |
Open | High | Low | Value | Volume |
$12.62 | $12.99 | $12.61 | $210.9K | 16.57K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1099 | $12.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.98 | 246 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1099 | 12.620 |
1 | 800 | 12.500 |
1 | 60 | 12.250 |
1 | 85 | 11.620 |
1 | 1500 | 11.610 |
Price($) | Vol. | No. |
---|---|---|
12.980 | 246 | 1 |
13.000 | 100 | 1 |
13.100 | 1000 | 1 |
13.250 | 75 | 1 |
13.500 | 750 | 1 |
Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |